[
  {
    "ts": null,
    "headline": "Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals",
    "summary": "TEM secures multiple FDA clearances in 2025, boosting its AI-driven diagnostic portfolio across oncology and cardiology.",
    "url": "https://finnhub.io/api/news?id=e85271489869414e2e230a46ce210503bb6d2ced955128512ad120c3c5c07b59",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761571200,
      "headline": "Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals",
      "id": 137229080,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "TEM secures multiple FDA clearances in 2025, boosting its AI-driven diagnostic portfolio across oncology and cardiology.",
      "url": "https://finnhub.io/api/news?id=e85271489869414e2e230a46ce210503bb6d2ced955128512ad120c3c5c07b59"
    }
  },
  {
    "ts": null,
    "headline": "Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?",
    "summary": "GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.",
    "url": "https://finnhub.io/api/news?id=ac34a48efd20f64ed982bb938590cde25af7c4f99bff94c8c9d5081092d173db",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761571200,
      "headline": "Does GEHC Stock Deserve a Spot in Your Portfolio Ahead of Q3 Earnings?",
      "id": 137228776,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "GE HealthCare's Q3 results are expected to show steady growth from Imaging and Diagnostics, though tariffs may weigh on margins and EPS.",
      "url": "https://finnhub.io/api/news?id=ac34a48efd20f64ed982bb938590cde25af7c4f99bff94c8c9d5081092d173db"
    }
  }
]